Tag Archives: NASDAQ:DVAX

Volume Gainers Watch List: XOMA (NASDAQ:XOMA), Spectrum Pharmaceuticals (NASDAQ:SPPI) – XOMA, SPPI, AGN, BIOS, DVAX, XNPT

Posted on March 13, 2013 by Thomas Vedder

Tuesday’s trading session data confirmed that healthcare sector reacted positively and the major percentage gainer in sectors. BioScrip Inc (NASDAQ:BIOS) and Dynavax Technologies Corporation (NASDAQ:DVAX) were major percentage gainer in this sector while key percentage decliner was XenoPort, Inc (NASDAQ:XNPT).…

Posted in Latest Headlines, Services | Tagged AGN, Allergan, BIOS, BioScrip, DVAX, Dynavax Technologies, NASDAQ:BIOS, NASDAQ:DVAX, NASDAQ:SPPI, NASDAQ:XNPT, NASDAQ:XOMA, NYSE:AGN, Spectrum Pharmaceuticals, SPPI, XenoPort, XNPT, Xoma | Comments Off

Healthcare Sector Quick Highlights: Elan (NYSE:ELN), Amgen (NASDAQ:AMGN) – ELN, AMGN, PFE, ENDP, DVAX, SCLN

Posted on February 26, 2013 by Thomas Vedder

Investors responded negatively to the Healthcare stocks on Monday. Key movement were observed in Endo Health Solutions Inc (NASDAQ:ENDP) on percentage gainers side while Dynavax Technologies Corporation (NASDAQ:DVAX) and SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) were major prominent decliners.

Royalty Pharma Management …

Posted in Healthcare, Latest Headlines | Tagged Amgen, AMGN, DVAX, Dynavax Technologies, Elan, ELN, Endo Health Solutions, ENDP, NASDAQ:AMGN, NASDAQ:DVAX, NASDAQ:ENDP, NASDAQ:SCLN, NYSE:ELN, NYSE:PFE, PFE, Pfizer, SciClone, SCLN | Comments Off

Microsoft Corp. (NASDAQ:MSFT) Started Selling Low Priced Surface Tablet Computer – MSFT, DVAX

Posted on February 25, 2013 by Thomas Vedder

Microsoft Corp. (NASDAQ:MSFT) would start selling its Surface tablet computer in Japan in the beginning of coming month, the Nikkei reported in its Sunday morning edition.

The firm released the device, its initial tablet, in the US, China and away …

Posted in Latest Headlines | Tagged DVAX, Dynavax Technologies, Microsoft, MSFT, NASDAQ:DVAX, NASDAQ:MSFT | Comments Off

Pernix Therapeutics (NYSE:PTX) To Acquire Somaxon (SOMX); $25 Million Accord – PTX, CRME, DEPO, AGN, DVAX, AMRN, ALXA, PFE, JNJ

Posted on December 11, 2012 by Thomas Vedder

Pernix Therapeutics Holdings Inc (NYSE:PTX) reported on Tuesday that it is purchasing Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) in a stock-for-stock agreement, worth at $25 million.

The Woodlands, Texas based Pernix anticipates to benefit from Somaxon’s insomnia drug Silenor in the purchase, …

Posted in Healthcare, Latest Headlines | Tagged AGN, Alexza Pharmaceuticals, Allergan, ALXA, Amarin, AMRN, CARDIOME PHARMA, CRME, DEPO, Depomed, DVAX, Dynavax Technologies, JNJ, Johnson & Johnson, NASDAQ:ALXA, NASDAQ:AMRN, NASDAQ:CRME, NASDAQ:DEPO, NASDAQ:DVAX, NYSE:AGN, NYSE:JNJ, NYSE:PFE, NYSEAMEX:PTX, Pernix Therapeutics, PFE, Pfizer, PTX | Comments Off

Acadia Healthcare (NASDAQ:ACHC) Unveils 9.6 Million Share Offering to Fund Acquisitions – ACHC, UHS, FB, PFE, GALE, JNJ, HOLX, PPHM, DVAX

Posted on December 4, 2012 by Geoff Noir

Acadia Healthcare Company Inc (NASDAQ:ACHC) has announced a 9.6 million share offering as the company looks to raise proceeds to support purchases.

The behavioral-health services company will offer 6 million shares, while the rest will be offered by certain selling …

Posted in Healthcare, Latest Headlines | Tagged Acadia Healthcare, ACHC, DVAX, Dynavax, Facebook, FB, GALE, Galena, Hologic, HOLX, JNJ, Johnson, NASDAQ:ACHC, NASDAQ:DVAX, NASDAQ:FB, NASDAQ:GALE, NASDAQ:HOLX, NASDAQ:PPHM, NYSE:JNJ, NYSE:PFE, NYSE:UHS, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM, UHS, Universal Health Services | Comments Off

Medtronic (NYSE:MDT) Posts Lower Profits on Higher Legal and Other Outlays – BSX, STJ, ARNA, JNJ, DVAX, MRK, PFE, BMTI

Posted on November 20, 2012 by Thomas Vedder

Medtronic, Inc (NYSE:MDT) on Tuesday posted a lower quarterly earnings as legal and other outlays ate into profits.

The medical technology company announced net earnings were $646 million or 63 cents a share in fiscal second quarter finished Oct 26, …

Posted in Healthcare, Latest Headlines | Tagged Arena Pharmaceuticals, ARNA, BioMimetic Therapeutics, BMTI, Boston Scientific, BSX, DVAX, Dynavax Technologies, JNJ, Johnson & Johnson, MDT, Medtronic, Merck, MRK, NASDAQ:ARNA, NASDAQ:BMTI, NASDAQ:DVAX, NYSE:BSX, NYSE:JNJ, NYSE:MDT, NYSE:MRK, NYSE:PFE, NYSE:STJ, PFE, Pfizer, St. Jude Medical, STJ | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.